pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
GLK-221
Keratoconus
$GKOS
GLAUKOS Corp
0
catalysts
Phase 2
GLK-302
pilocarpine
Presbyopia
Muscarinic acetylcholine receptor M1
Muscarinic acetylcholine receptor M3
$GKOS
GLAUKOS Corp
0
catalysts
Phase 2
GLK-321
Demodex Blepharitis
$GKOS
GLAUKOS Corp
← prev
page 13 of 50
next →
131
Pain
89
Neurology
1
0
catalysts
Phase 2
GLK-401
Age Related Macular Degeneration
$GKOS
GLAUKOS Corp
0
catalysts
Phase 2
GLY-200
Type 2 Diabetes
Glyscend Inc
0
catalysts
Phase 2
GNT-0003
Crigler-Najjar Syndrome
Genethon SA
0
catalysts
Phase 2
GO-2032c
Refractory Acute Myeloid Leukemia
Genus Oncology LLC
0
catalysts
Phase 2
GP-531
Congestive Heart Failure (Heart Failure)
ViCardia Therapeutics Inc
0
catalysts
Phase 2
GRC-54276
Bile Duct Cancer (Cholangiocarcinoma)
Ichnos Glenmark Innovation
0
catalysts
Phase 2
GRF-312
Keratoconjunctivitis Sicca (Dry Eye)
$GRFS
Grifols SA
0
catalysts
Phase 2
GS-030
Retinitis Pigmentosa (Retinitis)
GenSight Biologics SA
0
catalysts
Phase 2
GSK-101
Human Epidermal Growth Factor Receptor 2 Low Breast Cancer (HER2 Low Breast C…
Sodium channel protein type 9 subunit alpha
$GSK
GSK plc
0
catalysts
Phase 2
GSK-4382276A
Seasonal Influenza
$GSK
GSK plc
0
catalysts
Phase 2
GSK-5536522
Influenza A Virus, H5N1 Subtype Infections
$GSK
GSK plc
0
catalysts
Phase 2
GV-200251
Cervical Cancer
GV20 Therapeutics LLC
0
catalysts
Phase 2
Gene Therapy to Activate Artemis for Severe Combined Immune Deficiency
Severe Combined Immune Deficiency (SCID)
University of California San Francisco
0
catalysts
Phase 2
Gene Therapy to Activate IL-2 Gamma Receptor for SCID-X1
X-Linked SCID
Boston Children's Hospital
0
catalysts
Phase 2
Gene Therapy to Activate Retinoschisin for X-Linked Retinoschisis
Retinal Degeneration
National Eye Institute
0
catalysts
Phase 2
H-002
Non-Small Cell Lung Cancer
RedCloud Bio Inc
0
catalysts
Phase 2
H-1337
Open-Angle Glaucoma
D. Western Therapeutics Institute Inc
0
catalysts
Phase 2
HB-adMSC Allogeneic
Crohn's Disease (Regional Enteritis)
Hope Biosciences LLC
0
catalysts
Phase 2
HBI-3000
Atrial Fibrillation
HUYA Bioscience International LLC
0
catalysts
Phase 2
HCW-9218
Metastatic Pancreatic Cancer
$HCWB
HCW Biologics Inc.
0
catalysts
Phase 2
HLD-0915
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Halda Therapeutics LLC
0
catalysts
Phase 2
HLP-004
Generalized Anxiety Disorder (GAD)
HELUS Pharma
0
catalysts
Phase 2
HM-15275
Obesity
Hanmi Pharmaceuticals Co Ltd
0
catalysts
Phase 2
HMBD-002
Dedifferentiated Liposarcoma
Percheron Therapeutics Ltd
0
catalysts
Phase 2
HMI-115
Endometriosis
Hope Medicine Inc
0
catalysts
Phase 2
HMPLA-251
Solid Tumor
$HCM
HUTCHMED (China) Ltd
0
catalysts
Phase 2
HMPLA-580
Solid Tumor
$HCM
HUTCHMED (China) Ltd
0
catalysts
